Event Brief
Mar 10, 2026 at 1:06 PM ET
FDA Questions Leucovorin's Efficacy for Autism
By The BriefBrief
FDA finds limited evidence supporting leucovorin for autism, approving it only for a rare genetic disorder.
WHO: FDA
WHAT: Approved leucovorin for a rare brain disorder
WHEN: Mar 10, 2026 at 12:10 PM ET
WHERE: Washington
WHY: To clarify the drug's use amid claims of its efficacy for autism
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Saudi Arabia delays response to UAE leaving Opec
Saudi Arabia
May 1, 2026 at 3:23 PM ET
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21438 of 21438
Same format. Every time.
Continue reading — sign in or create a free account with
